JK

Jose Kaithapparambil Kurian

Active Director Designated Partner DIN 11011512
DIN 11011512 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jose Kaithapparambil Kurian

Data last updated:

Jose Kaithapparambil Kurian is a Designated Partner at Medicaura Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11011512
Primary Designation Designated Partner
Industry Pharma
First Appointment 21 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Mar 20252025Active

Board colleagues of Jose Kaithapparambil Kurian

NameDINCompanyDesignation
Mariamma Jose11011513Medicaura Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medicaura Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Jose Kaithapparambil Kurian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jose Kaithapparambil Kurian

Jose Kaithapparambil Kurian currently holds 1 directorship: Medicaura Pharmaceuticals Llp (Designated Partner, since 21 Mar 2025).

Jose Kaithapparambil Kurian was first appointed on 21 Mar 2025 as Designated Partner at Medicaura Pharmaceuticals Llp.

The current boards of Jose Kaithapparambil Kurian's companies include Mariamma Jose (Medicaura Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available